The Global Allergy Immunotherapy Market Growth Accelerated By Increasing Prevalence Of Allergic Diseases
![]() |
| Allergy Immunotherapy Market |
Allergy immunotherapy aims to treat different types of allergies including food, drug, insect and environmental allergies. It involves exposing individuals to small amounts of allergen to induce tolerance and reduce sensitivity. Allergy immunotherapy products such as sublingual immunotherapy tablets and subcutaneous immunotherapy injections are used for desensitization.
The global Allergy
Immunotherapy Market is estimated to be valued at US$ 2664.34 Mn in 2023 and
is expected to exhibit a CAGR of 5.9% over the forecast period 2024 to 2031, as
highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing prevalence of allergic diseases is one of the key trends driving
the growth of the allergy immunotherapy market. Allergic diseases are on the
rise globally due to changing environmental conditions and exposure to indoor
and outdoor allergens. According to a report by the Asthma and Allergy
Foundation of America, more than 50 million Americans suffer from allergies
every year. The growing burden of allergic diseases like allergic rhinitis,
asthma and food allergy has increased the demand for effective and long term
treatments such as allergy immunotherapy. Allergy immunotherapy helps alter the
natural progression of allergic diseases and provides long lasting relief by
inducing immune tolerance.
Segment Analysis
The global allergy immunotherapy market is dominated by subcutaneous
immunotherapy segment owing to its effectiveness and convenience of use at
home. Subcutaneous immunotherapy involves injecting antihistamines, steroid, or
allergen extracts under the skin which helps in reducing the symptoms of
allergies. Compared to other alternatives such as sublingual or oral
immunotherapy, subcutaneous route provides faster relief from allergic
reactions with long term benefits.
Key Takeaways
The global allergy immunotherapy market is expected to witness high growth over
the forecast period from 2024 to 2031. The global Allergy Immunotherapy Market
is estimated to be valued at US$ 2664.34
Mn in 2023 and is expected to
exhibit a CAGR of 5.9% over the forecast period 2024 to 2031.
Regional analysis: North America dominates the global market and is expected to
maintain its position during the forecast period. High healthcare expenditure
and increasing adoption of advanced therapeutics drive the market growth in the
region. Asia Pacific is expected to be the fastest growing market owing to
growing awareness regarding allergy treatments and increasing healthcare
expenditure in developing countries such as India and China.
Key players: Key players operating in the allergy immunotherapy market are B.
Braun Vet Care GmbH, BioMedtrix, LLC, IMEX Veterinary, Inc., Innoplant
Medizintechnik GmbH, KYON AG, Orthomed (UK) Ltd., BLUESAO Co. Ltd., New
Generation Devices (NGD), Johnson & Johnson, MWI Animal Health,
AmerisourceBergen Corporation, Platon Japan Co., Ltd.
Explore more related
article on this topic: https://www.newswirestats.com/the-global-allergy-immunotherapy-market-growth-analysis/
https://masstamilan.tv/recombinant-protein-the-future-of-biomanufacturing/

Comments
Post a Comment